Cargando…

Extravascular Dermal Trypanosomes in Suspected and Confirmed Cases of gambiense Human African Trypanosomiasis

BACKGROUND: The diagnosis of gambiense human African trypanosomiasis (gHAT) typically involves 2 steps: a serological screen, followed by the detection of living trypanosome parasites in the blood or lymph node aspirate. Live parasites can, however, remain undetected in some seropositive individuals...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camara, Mariame, Soumah, Alseny M’mah, Ilboudo, Hamidou, Travaillé, Christelle, Clucas, Caroline, Cooper, Anneli, Kuispond Swar, Nono-Raymond, Camara, Oumou, Sadissou, Ibrahim, Calvo Alvarez, Estefania, Crouzols, Aline, Bart, Jean-Mathieu, Jamonneau, Vincent, Camara, Mamadou, MacLeod, Annette, Bucheton, Bruno, Rotureau, Brice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246823/ https://www.ncbi.nlm.nih.gov/pubmed/32638003 http://dx.doi.org/10.1093/cid/ciaa897

Ejemplares similares

Immune trypanolysis test as a promising bioassay to monitor the elimination of gambiense human African trypanosomiasis
por: Dama, Emilie, et al.
Publicado: (2019)

Impact of the Ebola outbreak on Trypanosoma brucei gambiense infection medical activities in coastal Guinea, 2014-2015: A retrospective analysis from the Guinean national Human African Trypanosomiasis control program
por: Camara, Mariame, et al.
Publicado: (2017)

Accuracy of Individual Rapid Tests for Serodiagnosis of Gambiense Sleeping Sickness in West Africa
por: Jamonneau, Vincent, et al.
Publicado: (2015)

The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense
por: Leong, Smiths, et al.
Publicado: (2013)

Correction: The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense
por: Lueong, Smiths, et al.
Publicado: (2013)

APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis
por: Cooper, Anneli, et al.
Publicado: (2017)

Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in Guinea
por: Kaboré, Justin Windingoudi, et al.
Publicado: (2017)

The skin is a significant but overlooked anatomical reservoir for vector-borne African trypanosomes
por: Capewell, Paul, et al.
Publicado: (2016)

Performance of clinical signs and symptoms, rapid and reference laboratory diagnostic tests for diagnosis of human African trypanosomiasis by passive screening in Guinea: a prospective diagnostic accuracy study
por: Camara, Oumou, et al.
Publicado: (2023)

Unravelling Human Trypanotolerance: IL8 is Associated with Infection Control whereas IL10 and TNFα Are Associated with Subsequent Disease Development
por: Ilboudo, Hamidou, et al.
Publicado: (2014)

Resolving the apparent transmission paradox of African sleeping sickness
por: Capewell, Paul, et al.
Publicado: (2019)

The study of trypanosome species circulating in domestic animals in two human African trypanosomiasis foci of Côte d'Ivoire identifies pigs and cattle as potential reservoirs of Trypanosoma brucei gambiense
por: N’Djetchi, Martial Kassi, et al.
Publicado: (2017)

Monitoring the elimination of gambiense human African trypanosomiasis in the historical focus of Batié, South–West Burkina Faso
por: Compaoré, Charlie Franck Alfred, et al.
Publicado: (2022)

Untreated Human Infections by Trypanosoma brucei gambiense Are Not 100% Fatal
por: Jamonneau, Vincent, et al.
Publicado: (2012)

Revisiting the Immune Trypanolysis Test to Optimise Epidemiological Surveillance and Control of Sleeping Sickness in West Africa
por: Jamonneau, Vincent, et al.
Publicado: (2010)

Sleeping sickness in the historical focus of forested Guinea: update using a geographically based method
por: Courtin, Fabrice, et al.
Publicado: (2019)

African Trypanosomiasis Gambiense, Italy
por: Bisoffi, Zeno, et al.
Publicado: (2005)

Trypa-NO! contributes to the elimination of gambiense human African trypanosomiasis by combining tsetse control with “screen, diagnose and treat” using innovative tools and strategies
por: Ndung’u, Joseph Mathu, et al.
Publicado: (2020)

Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections
por: Bucheton, B, et al.
Publicado: (2011)

Do Cryptic Reservoirs Threaten Gambiense-Sleeping Sickness Elimination?
por: Büscher, Philippe, et al.
Publicado: (2018)

Epidemiology of Sleeping Sickness in Boffa (Guinea): Where Are the Trypanosomes?
por: Kagbadouno, Moise Saa, et al.
Publicado: (2012)

Introducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasis
por: Ilboudo, Hamidou, et al.
Publicado: (2017)

Candidate genes-based investigation of susceptibility to Human African Trypanosomiasis in Côte d’Ivoire
por: Ahouty, Bernardin, et al.
Publicado: (2017)

Gambiense human African trypanosomiasis: the bumpy road to elimination
por: Hasker, Epco, et al.
Publicado: (2022)

Accuracy of Five Algorithms to Diagnose Gambiense Human African Trypanosomiasis
por: Checchi, Francesco, et al.
Publicado: (2011)

Is vector control needed to eliminate gambiense human African trypanosomiasis?
por: Solano, Philippe, et al.
Publicado: (2013)

Monitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis
por: Simarro, Pere P., et al.
Publicado: (2015)

Treatment options for second-stage gambiense human African trypanosomiasis
por: Eperon, Gilles, et al.
Publicado: (2014)

Village-scale persistence and elimination of gambiense human African trypanosomiasis
por: Davis, Christopher N., et al.
Publicado: (2019)

SNPs in IL4 and IFNG show no protective associations with human African trypanosomiasis in the Democratic Republic of the Congo: a case-control study
por: Fataki Asina, Olivier, et al.
Publicado: (2020)

Accelerating elimination of sleeping sickness from the Guinean littoral through enhanced screening in the post-Ebola context: A retrospective analysis
por: Camara, Oumou, et al.
Publicado: (2021)

Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial
por: Betu Kumeso, Victor Kande, et al.
Publicado: (2023)

Syndromic Algorithms for Detection of Gambiense Human African Trypanosomiasis in South Sudan
por: Palmer, Jennifer J., et al.
Publicado: (2013)

First WHO Meeting of Stakeholders on Elimination of Gambiense Human African Trypanosomiasis
por: Holmes, Peter
Publicado: (2014)

Serological tests for gambiense human African trypanosomiasis detect antibodies in cattle
por: Matovu, Enock, et al.
Publicado: (2017)

Towards the sustainable elimination of gambiense human African trypanosomiasis in Côte d’Ivoire using an integrated approach
por: Kaba, Dramane, et al.
Publicado: (2023)

In Silico Identification of a Candidate Synthetic Peptide (Tsgf1(18–43)) to Monitor Human Exposure to Tsetse Flies in West Africa
por: Dama, Emilie, et al.
Publicado: (2013)

Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection
por: Ngay Lukusa, Ipos, et al.
Publicado: (2021)

Early Prediction of Treatment Efficacy in Second-Stage Gambiense Human African Trypanosomiasis
por: Priotto, Gerardo, et al.
Publicado: (2012)

Updated estimate of the duration of the meningo-encephalitic stage in gambiense human African trypanosomiasis
por: Checchi, Francesco, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uu48uq21tkt4413k5tnch0ii1v